Quinine

Lore & Background

The class of chemical compounds to which it belongs is called the cinchona alkaloids. Quinine is used to treat malaria and babesiosis, and is on the World Health Organization's List of Essential Medicines. It is also used to treat lupus and arthritis. Quinine is a flavor component of tonic water and bitter lemon soft drinks. Tonic water was initially marketed as a means of delivering quinine for anti-malarial protection. According to tradition, British colonials in India mixed it with gin to create the gin and tonic cocktail. As a flavoring agent in drinks, quinine is limited to 83 ppm in the United States, 85 mg/L in Taiwan, and 100 mg/L in the European Union.

Reader's Guide

Quinine's significance lies in its historical role as the first known chemical compound used to treat an infectious disease, specifically malaria. Despite being superseded as a first-line treatment by artemisinins due to side effects, quinine remains on the WHO's List of Essential Medicines for use when artesunate is unavailable, particularly against chloroquine-resistant Plasmodium falciparum. Its legacy extends beyond medicine: quinine's bitter flavor defines tonic water and inspired the gin and tonic cocktail. In science, it serves as a fluorescence standard in photochemistry and as a chiral moiety in asymmetric synthesis. However, its narrow therapeutic index and risk of serious adverse effects—including cinchonism, cardiac arrhythmias, and blood disorders—limit its use. The drug also illustrates the tension between traditional remedies and modern pharmacology, as bark extracts were used for centuries before the compound was isolated and synthesized.

Did You Know?

• Treatment of malaria with quinine marks the first known use of a chemical compound to treat an infectious disease.
• Quinine is a flavor component of tonic water and is limited to 83 ppm in the United States as a flavoring agent.
• Quinine can cause cinchonism, a group of symptoms including headache, ringing in the ears, vision issues, and sweating.

From Cinchona Bark to Modern Medicine

Quinine's journey from a Peruvian tree to a globally recognized medicine spans nearly four centuries. Jesuit missionaries carried knowledge of cinchona bark to Spain as early as 1636, and extracts had been employed against malaria since at least 1632. The compound was not formally isolated until 1820, and its molecular formula was not determined until Adolph Strecker published his findings in 1854. That milestone marked the first documented instance of a specific chemical compound being deployed to combat an infectious disease. Today, quinine remains on the World Health Organization's List of Essential Medicines, though its clinical role has shifted. Since 2006, the WHO no longer recommends it as a first-line antimalarial, preferring artemisinins that carry fewer side effects. Quinine now serves as a critical fallback for chloroquine-resistant Plasmodium falciparum when artesunate is unavailable. Beyond malaria, it is prescribed for babesiosis, lupus, and arthritis, and its ability to inhibit monoamine oxidase has sparked interest in its potential as a treatment for psychological disorders, echoing the mechanism of certain antidepressants.

A Narrow Therapeutic Window

Quinine occupies a precarious space between healing and harm. The margin separating its therapeutic dose from its toxic threshold is remarkably small, making it a frequent culprit behind drug-induced disorders such as thrombocytopenia and thrombotic microangiopathy. Even the trace amounts found in everyday beverages can, in susceptible individuals, trigger cascading effects across multiple organ systems—immune disruption, fever, hypotension, hemolytic anemia, acute kidney injury, liver toxicity, and in extreme cases, blindness. Common adverse reactions include headache, tinnitus, visual disturbances, and profuse sweating, while more serious outcomes encompass permanent hearing loss, dangerously low platelet counts, and cardiac arrhythmias. Patients with atrial fibrillation, conduction defects, or heart block face particular danger and should avoid the drug entirely. In 2010, the US FDA issued a warning that the once-common practice of prescribing quinine for nocturnal leg cramps carried a risk of life-threatening side effects, and its use for that purpose has since declined sharply. Additionally, quinine's potent inhibition of the CYP2D6 enzyme can elevate plasma levels of co-administered drugs that rely on that metabolic pathway.

The Bitter Taste That Built a Cocktail Culture

Long before quinine became a pharmacological curiosity, its distinctive bitterness shaped global drinking traditions. Tonic water was originally conceived as a practical vehicle to deliver quinine's anti-malarial properties to consumers, and on many bar soda guns it is still identified simply by the letter "Q." According to tradition, British colonists stationed in India found the medicinal tonic too harsh to drink straight and blended it with gin, giving birth to the gin and tonic—a cocktail that remains a bar staple worldwide. The reality, however, is that while one could theoretically consume enough tonic water to reach temporarily protective quinine levels, it is not a viable long-term antimalarial strategy. Quinine's flavoring role extends far beyond tonic: in France it appears in the apéritifs quinquina and Dubonnet; in Spain it is folded into sweet Malaga wine to produce Malaga Quina; in Italy it is infused into Barolo Chinato; in Britain, A.G. Barr uses it in Irn-Bru; in Uruguay and Argentina it flavors PepsiCo's Paso de los Toros; and in Denmark it is an ingredient in Royal Unibrew's Faxe Kondi. Regulatory limits on its concentration vary by region, ranging from 83 mg/L in the United States to 100 mg/L in the European Union.

Molecular Architecture and Laboratory Utility

Chemically, quinine is a naturally occurring alkaloid belonging to the cinchona alkaloid class, defined by a C9H7N quinoline functional group in which a pyridine ring is fused to a benzene ring. As a basic amine, it is almost always formulated as a salt—common preparations include the hydrochloride, dihydrochloride, sulfate, bisulfate, and gluconate forms. In the United States, quinine sulfate is sold commercially as 324 mg tablets under the brand name Qualaquin. While all quinine salts can be administered orally or intravenously, the gluconate variant additionally permits intramuscular and rectal delivery, though rectal dosing carries the practical drawback that the dose may be expelled before full absorption, typically corrected by administering a supplementary half dose. Notably, no injectable quinine preparation holds a US license; quinidine fills that role instead. Beyond pharmacology, quinine and its stereoisomer quinidine serve as chiral building blocks for ligands in Sharpless asymmetric dihydroxylation and numerous other chiral catalyst frameworks. Its remarkably consistent and well-characterized fluorescence quantum yield also makes it a standard reference compound in photochemical research.